Procaps Group (NASDAQ:PROC) Trading Down 40.3% – Here’s Why

Procaps Group S.A. (NASDAQ:PROC)’s share price dropped 40.3% during mid-day trading on Friday . The stock traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares changed hands during trading, an increase of 1,594% from the average daily volume of 38,864 shares. The stock had previously closed at $1.59.

Procaps Group Stock Down 40.3 %

The company has a 50 day moving average of $1.24 and a 200 day moving average of $1.68.

Institutional Trading of Procaps Group

An institutional investor recently bought a new position in Procaps Group stock. Itau Unibanco Holding S.A. purchased a new stake in shares of Procaps Group S.A. (NASDAQ:PROC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned approximately 0.16% of Procaps Group at the end of the most recent quarter.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.